Delivery Order SPE2DR25D2108-SPE2DR26F6SB9
- Not listed
- The Defense Logistics Agency awarded a $22,563.80 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This firm fixed-price, non-set-aside contract has an ultimate completion date of January 9, 2026, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $38,522.61 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,107.42 for Zepbound 7.5 mg/0.5 ml pen injections, with an ultimate completion date of December 18, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 potential value...
- The Defense Logistics Agency has awarded a delivery order valued at $1,107.42 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pen injections. The contract, effective through October 27, 2025, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $12,558.34 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. The contract employs firm fixed pricing and carries an ultimate completion date of December 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,819.99 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on December 19, 2025. This is a firm fixed price delivery order with an ultimate completion date of December 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. No...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors valued at $1,383.99 with an ultimate completion date of December 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $4,042.74 by the Defense Logistics Agency (DLA) for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with an ultimate completion date of December 11, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $33,241.61 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of December 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $44,644.60 by the Defense Logistics Agency on September 23, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 24, 2025. The award represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DR25D2108Indefinite Delivery Contract
- SPE2DR25D2108-SPE2DR26F6SB9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $34,315.38 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation, featuring an ultimate completion date of January 12, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 2031 that enables the company to deliver a wide range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs globally. AmerisourceBergen Drug Corp serves as a critical vendor in the federal pharmaceutical supply chain, regularly fulfilling federal medical procurement needs for military and veteran healthcare systems through its extensive contract portfolio with the Defense Logistics Agency. The company's track record demonstrates consistent capability in delivering brand-name and generic medications across multiple therapeutic domains on a competitive basis. The Zepbound order supports the Department of Defense's medical supply requirements, reflecting the company's ongoing role as a primary pharmaceutical distributor for federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.3k | 1/8/26 |